Meridiem Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $92.8K | Sell |
500
-685
| -58% | -$127K | ﹤0.01% | 43 |
|
|
2025
Q1 | $248K | Sell |
1,185
-750
| -39% | -$157K | ﹤0.01% | 37 |
|
|
2024
Q4 | $344K | Hold |
1,935
| – | – | 0.01% | 33 |
|
|
2024
Q3 | $382K | Hold |
1,935
| – | – | 0.01% | 35 |
|
|
2024
Q2 | $332K | Hold |
1,935
| – | – | 0.01% | 35 |
|
|
2024
Q1 | $352K | Hold |
1,935
| – | – | 0.01% | 35 |
|
|
2023
Q4 | $300K | Buy |
1,935
+750
| +63% | +$116K | 0.01% | 43 |
|
|
2023
Q3 | $177K | Hold |
1,185
| – | – | ﹤0.01% | 43 |
|
|
2023
Q2 | $160K | Sell |
1,185
-215
| -15% | -$29K | ﹤0.01% | 48 |
|
|
2023
Q1 | $223K | Hold |
1,400
| – | – | 0.01% | 42 |
|
|
2022
Q4 | $226K | Hold |
1,400
| – | – | 0.01% | 45 |
|
|
2022
Q3 | $188K | Hold |
1,400
| – | – | 0.01% | 47 |
|
|
2022
Q2 | $215K | Hold |
1,400
| – | – | 0.01% | 47 |
|
|
2022
Q1 | $227K | Hold |
1,400
| – | – | 0.01% | 47 |
|
|
2021
Q4 | $190K | Hold |
1,400
| – | – | 0.01% | 52 |
|
|
2021
Q3 | $151K | Hold |
1,400
| – | – | 0.01% | 57 |
|
|
2021
Q2 | $158K | Hold |
1,400
| – | – | 0.01% | 58 |
|
|
2021
Q1 | $151K | Sell |
1,400
-366
| -21% | -$39.5K | 0.01% | 56 |
|
|
2020
Q4 | $189K | Buy |
+1,766
| New | +$189K | 0.01% | 48 |
|